HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 321 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $496,000 | +740.7% | 18,496 | +1332.7% | 0.57% | +848.3% |
| Q2 2021 | $59,000 | -52.4% | 1,291 | -56.5% | 0.06% | -55.9% |
| Q1 2021 | $124,000 | -63.5% | 2,966 | -62.7% | 0.14% | -64.1% |
| Q4 2020 | $340,000 | +45.9% | 7,952 | -10.6% | 0.38% | +60.6% |
| Q3 2020 | $233,000 | -88.0% | 8,895 | -91.3% | 0.24% | -67.8% |
| Q2 2020 | $1,939,000 | +6586.2% | 102,462 | +6336.1% | 0.73% | +1459.6% |
| Q1 2020 | $29,000 | -92.4% | 1,592 | -93.1% | 0.05% | -81.1% |
| Q3 2019 | $381,000 | -73.6% | 23,093 | -72.5% | 0.25% | -69.4% |
| Q2 2019 | $1,443,000 | – | 83,966 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |